Safety, pharmacokinetics, and pharmacodynamics of efzimfotase alfa, a second-generation enzyme replacement therapy: phase 1, dose-escalation study in adults with hypophosphatasia

Margaret Robb November 12, 2024

0 Comments

To read more please click on the link below.

Categories: Scientific Publications, Scientific Publications (new)

Tags: Adeno-associated virus vector, alkaline phosphatase, Genetic Therapies, hypophosphatasia, Progress, therapeutics

A Family’s Fight Against HPP

On December 21, 2011 our daughter Clara B. was born; at the time we believed she was a beautiful healthy baby girl. Little did we…

Taralyn Naslonski November 6, 2020

0 Comments

Letter to the Editor: “Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study”

To read more please click on the link below. Read Article

softbones October 28, 2020

0 Comments

Pharmacokinetics of Asfotase Alfa in Adult Patients With Pediatric‐Onset Hypophosphatasia

To read more please click on the link below. Read Article

Denise Goodbar April 9, 2021

0 Comments

Detection of hypophosphatasia in hospitalised adults in rheumatology and internal medicine departments: a multicentre study over 10 years

To read more please click on the link below. Read Article

Margaret Robb August 15, 2024

0 Comments

Five-Year Efficacy and Safety of Asfotase Alfa Therapy for Adults and Adolescents with Hypophosphatasia

To read more please click on the link below. Read Article

softbones October 28, 2020

0 Comments

Responses

You must be logged in to post a comment.

Mail Address (P.O Box)
The US Hypophosphatasia Foundation
141 Hawkins Place, #267
Boonton, NJ 07005, USA.

Organization

Programs

Community

Office Address (Location for meetings and events)
1719 NJ-10, Suite 315
Parsippany, NJ 07054

Follow Us on Social Media!

Disclaimer: This Website is owned by Soft Bones, Inc. All materials contained in this Website (the “Materials”) are either owned by or licensed to us and are protected by intellectual property and other laws. We retain all proprietary rights to the Materials. This Website is copyrighted. All rights are reserved. Except as expressly authorized by us, any use, copy, reproduction, display, performance, modification or retransmission of the Materials is strictly prohibited.

Related Articles

Responses